Use of beta-blockers, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and breast cancer survival: Systematic review and meta-analysis - Raimondi, S; Botteri, E; Munzone, E (Int J Cancer, 2016)
et al.